Does CISPLATIN\PACLITAXEL Cause Second primary malignancy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with CISPLATIN\PACLITAXEL. This represents 26.3% of all adverse event reports for CISPLATIN\PACLITAXEL.
5
Reports of Second primary malignancy with CISPLATIN\PACLITAXEL
26.3%
of all CISPLATIN\PACLITAXEL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From CISPLATIN\PACLITAXEL?
Of the 5 reports.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISPLATIN\PACLITAXEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CISPLATIN\PACLITAXEL Cause?
Acute myeloid leukaemia (8)
Lymphangioleiomyomatosis (8)
Blast cells present (5)
Haematocrit decreased (5)
Haemoglobin decreased (5)
Mean cell haemoglobin decreased (5)
Mean cell volume abnormal (5)
Neutrophil percentage decreased (5)
Platelet count decreased (5)
Red cell distribution width increased (5)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)